610 North Lincoln StreetWaltham, MA 02451
Paul Sohmer, M.D.
President & CEO
BG Medicine, Inc.
BG Medicine (NASDAQ: BGMD) is a publicly traded developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.
Noubar Afeyan is a Founder and serves on the Board of Directors and Stéphane Bancel is Executive Chairman of the Board.